Published in Am J Med on December 01, 2005
Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med (2006) 3.59
Association of the metabolic syndrome with pulmonary venous hypertension. Chest (2009) 2.75
EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Chest (2014) 1.88
PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail (2008) 1.75
High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail (2013) 1.70
Unrecognized glucose intolerance is common in pulmonary arterial hypertension. J Heart Lung Transplant (2011) 1.58
Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med (2008) 1.38
Poor outcomes associated with drainage of pericardial effusions in patients with pulmonary arterial hypertension. South Med J (2008) 1.30
Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2011) 1.25
Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest (2002) 1.21
Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming. Pulm Circ (2012) 1.19
A potential role for insulin resistance in experimental pulmonary hypertension. Eur Respir J (2012) 1.16
Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension. Nat Genet (2013) 1.11
The Diastolic Pressure Gradient Does Not-and Should Not-Predict Outcomes. JACC Heart Fail (2015) 1.10
Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 1.09
Oxidative injury is a common consequence of BMPR2 mutations. Pulm Circ (2011) 1.06
Early use of non-invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler (2007) 1.05
ACE2 improves right ventricular function in a pressure overload model. PLoS One (2011) 1.03
Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression. Pulm Circ (2011) 1.00
BMPR2 expression is suppressed by signaling through the estrogen receptor. Biol Sex Differ (2012) 0.95
Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease. Womens Health (Lond Engl) (2010) 0.92
Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension. Chest (2012) 0.92
Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension. Am J Respir Crit Care Med (2015) 0.91
Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve (2006) 0.91
Supramaximal inflation improves lung compliance in subjects with amyotrophic lateral sclerosis. Chest (2006) 0.89
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment. Amyotroph Lateral Scler Other Motor Neuron Disord (2002) 0.87
Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function. Pulm Circ (2013) 0.87
Right ventricular plasticity and functional imaging. Pulm Circ (2012) 0.87
Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension. JACC Heart Fail (2013) 0.87
Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertension. Exp Lung Res (2010) 0.86
An evidence-based knowledgebase of pulmonary arterial hypertension to identify genes and pathways relevant to pathogenesis. Mol Biosyst (2014) 0.84
Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension. Am J Respir Cell Mol Biol (2013) 0.84
Persistent lower abdominal and groin pain: what is the diagnosis? Am J Med (2005) 0.83
Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2004) 0.83
Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity. Cardiovasc Res (2011) 0.83
Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension. Chest (2015) 0.82
Hysteroscopic sterilization in women with pulmonary vascular disease. Mayo Clin Proc (2008) 0.80
Hemodynamic improvement of pulmonary arterial hypertension after bariatric surgery: potential role for metabolic regulation. Diabetes Care (2013) 0.80
Combination therapy in pulmonary arterial hypertension. Clin Chest Med (2013) 0.80
Elevation of plasma cell-free hemoglobin in pulmonary arterial hypertension. Chest (2014) 0.80
Pulmonary hypertension in women. Expert Rev Cardiovasc Ther (2010) 0.79
Left atrial hypertension after repeated catheter ablations for atrial fibrillation. J Am Coll Cardiol (2011) 0.78
Programmatic change: lung disease research in the era of induced pluripotency. Am J Physiol Lung Cell Mol Physiol (2011) 0.77
Metabolic Dysfunction in Pulmonary Arterial Hypertension. Curr Hypertens Rep (2015) 0.76
Reproducibility of intracardiac and transpulmonary biomarkers in the evaluation of pulmonary hypertension. Pulm Circ (2013) 0.75
New recommendations on duty hours from the ACGME. N Engl J Med (2010) 0.75
Predictors of diastolic-to-wedge gradient in patients evaluated for pulmonary hypertension. PLoS One (2013) 0.75
The right ventricle in pulmonary hypertension: from dogma to data. Am J Respir Crit Care Med (2010) 0.75
Vasodilator-responsive idiopathic pulmonary arterial hypertension: evidence for a new disease? Ann Intern Med (2015) 0.75
Host to an intruder. Am J Med (2005) 0.75
Growth by association. Am J Med (2007) 0.75
Diagnosing acute pancreatitis. Am J Med (2005) 0.75
All in the family. Am J Med (2006) 0.75
An unusual development. Am J Med (2005) 0.75
A necessary detour. Am J Med (2006) 0.75
An unexpected finding. Am J Med (2005) 0.75